工程小说 两白金 (Amphiphilic Platinum) ......IV) 复合物 共同提供西斯白金和多克索鲁比
Wjdan Jogadi1, Man B Kshetri1, Suha Alqarni1,2
1Department of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.
Molecules (Basel, Switzerland)
|September 14, 2024
概括
与现有治疗方法相比,一种新的-多克索鲁比辛结合物显示出更好的杀癌能力. 这种新药有效地将和多克索鲁比辛的有效载荷输送到癌细胞中,增强DNA损伤和治疗疗效.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 药物运输 药物运输 药物运输
背景情况:
- 西斯普拉丁和多克索鲁比辛是标准化疗剂,但具有局限性.
- 组合疗法旨在提高疗效,但可以增加毒性.
- 需要新的药物输送系统来增强治疗指数.
研究的目的:
- 为了合成和表征一种新的两性-多克索鲁比联合体.
- 为了评估结合物的细胞内传递和DNA损伤潜力.
- 评估结合剂对癌细胞的体外细胞毒性和选择性.
主要方法:
- 合成一种两性Pt(IV) -多克索鲁比联合物 (1).
- 使用石墨炉原子吸收光谱和光成像,评估细胞内有效载荷的积累.
- 通过化H2AX (γH2AX) 流细胞计对核DNA损伤的评估.
- 用MTT活力测试对MDA-MB-231乳腺癌细胞进行细胞毒性和选择性测试.
主要成果:
- Pt(IV) -多克索鲁比辛合物 (1) 证明了白金和多克索鲁比辛的有效细胞内传递.
- 综合体1显著诱导核DNA损伤,由高的γH2AX水平证明.
- 与单个药物或它们的组合相比,MTT测定显示了对人类癌细胞的结合物1的优异细胞毒性和选择性.
结论:
- 开发的两性Pt(IV) -多克索鲁比辛结合物代表了癌症治疗的有前途的新策略.
- 这种新型的结合物通过改善细胞内传递和DNA损伤诱导表现出增强的治疗效果.
- 这种分子设计为结合化疗提供了潜在的进步,并改善了治疗指数.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
5.9K
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
